RMD vs. EME

Last updated Apr 1, 2026

Compare and contrast key facts about ResMed Inc. (RMD) and EMCOR Group, Inc. (EME).

Performance

RMD vs. EME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and EMCOR Group, Inc. (EME). The values are adjusted to include any dividend payments, if applicable.

RMD vs. EME - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RMD ResMed Inc.	-6.59%	6.26%	34.18%	-16.55%	-19.47%	23.41%	38.33%	37.85%	36.38%	39.06%
EME EMCOR Group, Inc.	20.75%	35.05%	111.27%	46.03%	16.81%	39.93%	6.47%	45.18%	-26.68%	16.09%

Fundamentals

EPS RMD : $15.16 EME : $28.22
PE Ratio RMD : 14.81 EME : 26.17
PEG Ratio RMD : 0.46 EME : 0.61
PS Ratio RMD : 4.08 EME : 1.96
Total Revenue (TTM) RMD : $5.40B EME : $16.99B
Gross Profit (TTM) RMD : $3.29B EME : $3.33B
EBITDA (TTM) RMD : $1.96B EME : $1.84B

Returns By Period

In the year-to-date period, RMD achieves a -6.59% return, which is significantly lower than EME's 20.75% return. Over the past 10 years, RMD has underperformed EME with an annualized return of 15.62%, while EME has yielded a comparatively higher 31.80% annualized return.

RMD

• 1D: 2.02%
• 1M: -12.40%
• YTD: -6.59%
• 6M: -17.61%
• 1Y: 1.18%
• 3Y*: 1.78%
• 5Y*: 3.81%
• 10Y*: 15.62%

EME

• 1D: 5.31%
• 1M: 1.89%
• YTD: 20.75%
• 6M: 13.78%
• 1Y: 100.16%
• 3Y*: 66.05%
• 5Y*: 45.89%
• 10Y*: 31.80%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RMD vs. EME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMD

RMD Risk / Return Rank: 41
RMD Sharpe Ratio Rank: 44
RMD Sortino Ratio Rank: 37
RMD Omega Ratio Rank: 36
RMD Calmar Ratio Rank: 45
RMD Martin Ratio Rank: 46

EME

EME Risk / Return Rank: 91
EME Sharpe Ratio Rank: 95
EME Sortino Ratio Rank: 90
EME Omega Ratio Rank: 92
EME Calmar Ratio Rank: 91
EME Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RMD vs. EME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and EMCOR Group, Inc. (EME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RMD	EME	Difference
Sharpe ratio Return per unit of total volatility	0.05	2.50	-2.46
Sortino ratio Return per unit of downside risk	0.26	2.80	-2.54
Omega ratio Gain probability vs. loss probability	1.03	1.42	-0.39
Calmar ratio Return relative to maximum drawdown	0.12	3.96	-3.84
Martin ratio Return relative to average drawdown	0.28	10.24	-9.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RMD vs. EME - Sharpe Ratio Comparison

The current RMD Sharpe Ratio is 0.05, which is lower than the EME Sharpe Ratio of 2.50. The chart below compares the historical Sharpe Ratios of RMD and EME, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RMD	EME	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.05	2.50	-2.46
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.12	1.40	-1.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.50	0.97	-0.48
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.59	-0.06

Correlation

The correlation between RMD and EME is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RMD vs. EME - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 1.04%, more than EME's 0.16% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RMD ResMed Inc.	1.04%	0.94%	0.88%	1.07%	0.83%	0.62%	0.73%	0.98%	1.26%	1.61%	2.03%	2.16%
EME EMCOR Group, Inc.	0.16%	0.16%	0.20%	0.32%	0.36%	0.41%	0.35%	0.37%	0.54%	0.39%	0.45%	0.67%

Drawdowns

RMD vs. EME - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.61%, smaller than the maximum EME drawdown of -70.56%. Use the drawdown chart below to compare losses from any high point for RMD and EME.

Drawdown Indicators

	RMD	EME	Difference
Max Drawdown Largest peak-to-trough decline	-61.61%	-70.56%	+8.95%
Max Drawdown (1Y) Largest decline over 1 year	-24.74%	-25.15%	+0.41%
Max Drawdown (5Y) Largest decline over 5 years	-53.99%	-36.19%	-17.80%
Max Drawdown (10Y) Largest decline over 10 years	-53.99%	-48.00%	-5.99%
Current Drawdown Current decline from peak	-23.22%	-9.16%	-14.06%
Average Drawdown Average peak-to-trough decline	-15.91%	-15.43%	-0.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.55%	9.72%	+0.83%

Volatility

RMD vs. EME - Volatility Comparison

The current volatility for ResMed Inc. (RMD) is 6.17%, while EMCOR Group, Inc. (EME) has a volatility of 11.59%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than EME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RMD	EME	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.17%	11.59%	-5.42%
Volatility (6M) Calculated over the trailing 6-month period	17.04%	32.46%	-15.42%
Volatility (1Y) Calculated over the trailing 1-year period	25.62%	40.22%	-14.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.07%	32.90%	-1.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.41%	32.75%	-1.34%

Financials

RMD vs. EME - Profitability Comparison

The chart below illustrates the profitability comparison between ResMed Inc. and EMCOR Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a gross profit of 878.72M and revenue of 1.42B. Therefore, the gross margin over that period was 61.8%.

EME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, EMCOR Group, Inc. reported a gross profit of 935.60M and revenue of 4.52B. Therefore, the gross margin over that period was 20.7%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported an operating income of 491.66M and revenue of 1.42B, resulting in an operating margin of 34.6%.

EME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, EMCOR Group, Inc. reported an operating income of 531.64M and revenue of 4.52B, resulting in an operating margin of 11.8%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ResMed Inc. reported a net income of 392.59M and revenue of 1.42B, resulting in a net margin of 27.6%.

EME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, EMCOR Group, Inc. reported a net income of 431.79M and revenue of 4.52B, resulting in a net margin of 9.6%.